Tilray Brands, Inc. (TLRY) 

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Show less

Over the last 12 months, insiders at Tilray Brands, Inc. have bought $183,210 and sold $0 worth of Tilray Brands, Inc. stock.

On average, over the past 5 years, insiders at Tilray Brands, Inc. have bought $183,210 and sold $36.41M worth of stock each year.

Highest buying activity among insiders over the last 12 months: SIMON IRWIN D (President and CEO) — $302,868. Gendel Mitchell (Global General Counsel) — $73,062. FALTISCHEK DENISE M (Chief Strategy Officer) — $61,500.

The last purchase of 10,000 shares for transaction amount of $20,500 was made by FALTISCHEK DENISE M (Chief Strategy Officer) on 2024‑01‑17.